Infectious Diseases and Nanomedicine III pp 51-61 | Cite as
Potential Treatment Options in a Post-antibiotic Era
Abstract
Following the Golden Age of antibiotic discovery in the previous century, the rate of antibiotic discovery has plummeted during the past 50 years while the incidence of antimicrobial resistance is ever-increasing. Presently, humankind is forced to address a major public health threat in the form of multiple drug resistance and urgent action is required to halt the advent of a post-antibiotic era. This chapter aims to draw the attention to the escalating global crisis of antimicrobial resistance fueled by the irresponsible use of antibiotics in healthcare and animal production sectors. The merits of alternative prevention and treatment options, including vaccines, herbal products, bacteriophages, and improved biosecurity measures are also discussed.
Keywords
Antibiotics Vaccines Essential oils Bacteriophages Antimicrobial resistanceReferences
- 1.Coates A, Halls G, Hu Y (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163:184–194CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Davies J (2006) Where have all the antibiotics gone? Can J Infect Dis Med Microbiol 17:287–290PubMedPubMedCentralGoogle Scholar
- 3.Natural Resources Defense Council (2016) New antibiotics scorecard: number of top restaurant chains restricting use in chicken doubled in 2016 [Internet]. https://www.nrdc.org/media/2016/160920. Accessed 27 July 2017
- 4.European Centre for Disease Control and Prevention (2009) The bacterial challenge: time to react [Internet]. Reproduction. 2009. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf
- 5.Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE (2004) Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 38:1279–1286CrossRefPubMedGoogle Scholar
- 6.Barbachyn MR, Ford CW (2003) Oxazolidinone structure-activity relationships leading to linezolid. Angew Chemie Int Ed 42:2010–2023CrossRefGoogle Scholar
- 7.Kern WV (2006) Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections. Int J Clin Pract 60:370–378CrossRefPubMedGoogle Scholar
- 8.O’Daniel PI, Peng Z, Pi H, Testero SA, Ding D, Spink E et al (2014) Discovery of a new class of non-B-lactam inhibitors of penicillin-binding proteins with gram-positive antibacterial activity. J Am Chem Soc 136:3664–3672CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Boyle W (1955) Spices and essential oils as preservatives. Am Perfum Essent Oil Rev 66:25–28Google Scholar
- 10.Isman MB, Miresmailli S, Machial C (2011) Commercial opportunities for pesticides based on plant essential oils in agriculture, industry and consumer products. Phytochem Rev 10:197–204CrossRefGoogle Scholar
- 11.Mith H, Duré R, Delcenserie V, Zhiri A, Daube G, Clinquart A (2014) Antimicrobial activities of commercial essential oils and their components against food-borne pathogens and food spoilage bacteria. Food Sci Nutr 2:403–416CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Bouaziz M, Yangui T, Sayadi S, Dhouib A (2009) Disinfectant properties of essential oils from Salvia officinalis L. cultivated in Tunisia. Food Chem Toxicol 47:2755–2760CrossRefPubMedGoogle Scholar
- 13.Ziosi P, Manfredini S, Vertuani S, Ruscetta V, Radice M, Sacchetti G et al (2010) Evaluating essential oils in cosmetics: antioxidant capacity and functionality. Cosmet Toilet 6:32–40Google Scholar
- 14.Manabe A, Nakayama S, Sakamoto K (1987) Effects of essential oils on erythrocytes and hepatocytes from rats and dipalmitoyl phosphatidylcholine-liposomes. Jpn J Pharmacol 44:77–84CrossRefPubMedGoogle Scholar
- 15.Jouany J-P, Morgavi DP (2007) Use of “natural” products as alternatives to antibiotic feed additives in ruminant production. Anim Int J Anim Biosci 1:1443–1466Google Scholar
- 16.Li P, Piao X, Ru Y, Han X, Xue L, Zhang H (2012) Effects of adding essential oil to the diet of weaned pigs on performance, nutrient utilization, immune response and intestinal health. Asian-Australasian J Anim Sci 25:1617–1626CrossRefGoogle Scholar
- 17.Bento MHL, Ouwehand AC, Tiihonen K, Lahtinen S, Nurminen P, Saarinen MT et al (2013) Essential oils and their use in animal feeds for monogastric animals-effects on feed quality, gut microbiota, growth performance and food safety: a review. Vet Med (Praha) 58:449–58Google Scholar
- 18.Barbour EK, Shaib H, Azhar E, Kumosani T, Iyer A, Harakeh S et al (2013) Modulation by essential oil of vaccine response and production improvement in chicken challenged with velogenic newcastle disease virus. J Appl Microbiol 115:1278–1286CrossRefPubMedGoogle Scholar
- 19.Barbour EK, Bragg RR, Karrouf G, Iyer A, Azhar E, Harakeh S et al (2015) Control of eight predominant Eimeria spp. involved in economic coccidiosis of broiler chicken by a chemically characterized essential oil. J Appl Microbiol 118:583–591CrossRefPubMedGoogle Scholar
- 20.Mishra RPN, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F (2012) Vaccines and antibiotic resistance. Curr Opin Microbiol 15:596–602CrossRefPubMedGoogle Scholar
- 21.Azzari C, Resti M (2008) Reduction of carriage and transmission of Streptococcus pneumoniae: The beneficial “side effect” of pneumococcal conjugate vaccine. Clin Infect Dis 47:997–999CrossRefPubMedGoogle Scholar
- 22.Gonçalves G (2008) Herd immunity: recent uses in vaccine assessment. Expert Rev Vaccines 7:1493–1506CrossRefPubMedGoogle Scholar
- 23.Serruto D, Serino L, Masignani V, Pizza M (2009) Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine 27:3245–3250CrossRefPubMedGoogle Scholar
- 24.Finco O, Rappuoli R (2014) Designing vaccines for the twenty-first century society. Front Immunol 5:1–6CrossRefGoogle Scholar
- 25.Rappuoli R (2001) Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19:2688–2691CrossRefPubMedGoogle Scholar
- 26.Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M et al (2000) Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816–1820CrossRefPubMedGoogle Scholar
- 27.Romero JD, Outschoorn IM (1994) Current status of meningococcal Group B vaccine candidates: capsular or noncapsular? Clin Microbiol Rev 7:559–575CrossRefGoogle Scholar
- 28.Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA et al (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 247:1809–1815CrossRefGoogle Scholar
- 29.Sette A, Rappuoli R (2012) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33:530–541CrossRefGoogle Scholar
- 30.Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317CrossRefGoogle Scholar
- 31.De La Cruz VF, Lal AA, McCutchan TF (1988) Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J Biol Chem 263:4318–4322PubMedGoogle Scholar
- 32.Van Houten NE, Zwick MB, Menendez A, Scott JK (2006) Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide. Vaccine 24:4188–4200CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Aghebati-Maleki L, Bakhshinejad B, Baradaran B, Motallebnezhad M, Aghebati-Maleki A, Nickho H et al (2016) Phage display as a promising approach for vaccine development. J Biomed Sci 23:1–18CrossRefGoogle Scholar
- 34.Wang H, Gao Y, Gong Y, Chen X, Liu C, Zhou X et al (2007) Identification and immunogenicity of an immunodominant mimotope of Avibacterium paragallinarum from a phage display peptide library. Vet Microbiol 119:231–239CrossRefPubMedGoogle Scholar
- 35.Elbreki M, Ross RP, Hill C, O’Mahony J, McAuliffe O, Coffey A (2014) Bacteriophages and their derivatives as biotherapeutic agents in disease prevention and treatment. J Viruses 2014:1–20CrossRefGoogle Scholar
- 36.Bragg R, Boucher C, van der Westhuizen W, Lee J-Y, Coetsee E, Theron C et al (2016) Bacteriophage therapy as a treatment option in a post-antibiotic era. In: Kon KV, Rai M (ed) Antibiotics resistant: mechanisms and new antimicrobial approaches, 1st ed. Elsevier, Amsterdam, pp 309–28Google Scholar
- 37.Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A (1987) Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch Immunol Ther Exp (Warsz) 35:569–83Google Scholar
- 38.Bhattacharya S (2010) The facts about penicillin allergy: a review. J Adv Pharm Technol Res 1:11–17PubMedPubMedCentralGoogle Scholar
- 39.Örmälä A, Jalasvuori M (2013) Should bacterial resistance to phages be a concern, even in the long run? Bacteriophage:3Google Scholar
- 40.Abedon ST (2012) Bacterial “immunity” against bacteriophages. Bacteriophage 2:50–54CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Labrie SJ, Samson JE, Moineau S (2010) Bacteriophage resistance mechanisms. Nat Rev Microbiol 8:317–327CrossRefPubMedGoogle Scholar
- 42.Barrangou R, Fremaux C, Devaux H, Richards M, Boyaval P, Moineau S et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709–1712CrossRefPubMedGoogle Scholar
- 43.Rath D, Amlinger L, Rath A, Lundgren M (2015) The CRISPR-Cas immune system: biology, mechanisms and applications. Biochimie 117:119–128CrossRefPubMedGoogle Scholar
- 44.Buckling A, Rainey PB (2002) Antagonistic coevolution between a bacterium and a bacteriophage. Proc R Soc London B:931–6CrossRefPubMedGoogle Scholar
- 45.Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR (2016) Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:429–432CrossRefGoogle Scholar
- 46.Seed KD, Lazinski DW, Calderwood SB, Camilli A (2013) A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494:489–491CrossRefPubMedPubMedCentralGoogle Scholar
- 47.Fischetti VA (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol 13:491–496CrossRefPubMedGoogle Scholar
- 48.Wang I-N, Smith DL, Young R (2000) Holins: The protein clocks of bacteriophage infections. Annu Rev Microbiol 54:799–825CrossRefPubMedGoogle Scholar
- 49.Catalão MJ, Gil F, Moniz-Pereira J, São-José C, Pimentel M (2013) Diversity in bacterial lysis systems: bacteriophages how the way. FEMS Microbiol Rev 37:554–571CrossRefPubMedGoogle Scholar
- 50.Tišáková L, Vidová B, Farkašovská J, Godány A (2014) Bacteriophage endolysin Lyt μ1/6: characterization of the C-terminal binding domain. FEMS Microbiol Lett 350:199–208CrossRefPubMedGoogle Scholar
- 51.Nelson D, Loomis L, Fischetti VA (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci 98:4107–4112CrossRefPubMedGoogle Scholar
- 52.Loeffler JM, Nelson D, Fischetti VA (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294:2170–2172CrossRefPubMedGoogle Scholar
- 53.Dong H, Zhu C, Chen J, Ye X, Huang YP (2015) Antibacterial activity of Stenotrophomonas maltophilia endolysin P28 against both gram-positive and gram-negative bacteria. Front Microbiol 6:1–8Google Scholar
- 54.Fernandes S, Proença D, Cantante C, Silva FA, Leandro C, Lourenço S et al (2012) Novel chimerical endolysins with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus. Microb Drug Resist 18:333–343CrossRefPubMedGoogle Scholar
- 55.Lu TK, Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci 104(27):11197–202CrossRefPubMedGoogle Scholar
- 56.Bragg RR (2004) Limitation of the spread and impact of infectious coryza through the use of a continuous disinfection programme. Onderstepoort J Vet Res 71:1–8PubMedGoogle Scholar
- 57.Bragg RR, Plumstead P (2003) Continuous disinfection as a means to control infectious diseases in poultry: evaluation of a continuous disinfection programme for broilers. Onderstepoort J Vet Res 70:219–229PubMedGoogle Scholar
- 58.Russell AD (1998) Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 43 (Supple):S57–68CrossRefPubMedGoogle Scholar
- 59.Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP (2010) Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb Drug Resist 16:91–104CrossRefPubMedGoogle Scholar
- 60.Russell AD (1997) Plasmids and bacterial resistance to biocides. J Appl Microbiol 83(2):155–65CrossRefPubMedGoogle Scholar
- 61.McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147–179PubMedPubMedCentralGoogle Scholar
- 62.Méchin L, Dubois-Brissonnet F, Heyd B, Leveau JY (1999) Adaptation of Pseudomonas aeruginosa ATCC 15442 to didecyldimethylammonium bromide induces changes in membrane fatty acid composition and in resistance of cells. J Appl Microbiol 86(5):859–66CrossRefPubMedGoogle Scholar
- 63.White DG, McDermott PF (2001) Emergence and transfer of antibacterial resistance. J Dairy Sci 84:E151–E155CrossRefGoogle Scholar
- 64.Paulsen IT, Park JH, Choi PS, Saier MH Jr (1997) A family of Gram-negative bacterial outer membrane factors that function in the export of protiens, carbohydrates, drugs and heavy metals from Gram-negative bacteria. FEMS Microbiol Lett 156:1–8CrossRefPubMedPubMedCentralGoogle Scholar
- 65.Adair FW, Geftic S, Gelzer J (1971) Resistance of Pseudomonas to quaternary ammonium compounds. Appl Microbiol 21:1058–1063PubMedPubMedCentralGoogle Scholar
- 66.Gilbert P, Collier PJ, Brown MR (1990) Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother 34:1865–1868CrossRefPubMedPubMedCentralGoogle Scholar
- 67.Campanac C, Pineau L, Payard A, Baziard-Mouysset G, Roques C (2002) Interactions between biocide cationic agents and bacterial biofilms. Antimicrob Agents Chemother 46:1469–1474CrossRefPubMedPubMedCentralGoogle Scholar
- 68.Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A (2012) Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds—a critical review. Int J Antimicrob Agents 39:381–389CrossRefPubMedGoogle Scholar
- 69.McBain AJ, Ledder RG, Moore LE, Carl E, Gilbert P, Catrenich CE (2004) Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol 70:3449–3456CrossRefPubMedPubMedCentralGoogle Scholar
- 70.Bjorland J, Sunde M, Waage S (2001) Plasmid-borne smr gene causes resistance to quaternary ammonium compounds in bovine Staphylococcus aureus. J Clin Microbiol 39:3999–4004CrossRefPubMedPubMedCentralGoogle Scholar
- 71.Bjorland J, Steinum T, Kvitle B, Waage S, Sunde M, Heir E (2005) Widespread distribution of disinfectant resistance genes among staphylococci of bovine and caprine origin in Norway. J Clin Microbiol 43:4363–4368CrossRefPubMedPubMedCentralGoogle Scholar
- 72.Ioannou CJ, Hanlon GW, Denyer SP (2007) Action of disinfectant quaternary ammonium compounds against Staphylococcus aureus. Antimicrob Agents Chemother 51:296–306CrossRefPubMedGoogle Scholar
- 73.Bjorland J, Steinum T, Sunde M, Waage S, Heir E (2003) Novel plasmid-borne gene qacJ mediates resistance to quaternary ammonium compounds in equine Staphylococcus aureus, Staphylococcus simulans, and Staphylococcus intermedius. Antimicrob Agents Chemother. 47(10):3046–52CrossRefPubMedPubMedCentralGoogle Scholar
- 74.Heir E, Sundheim G, Holck AL (1999) Identification and characterization of quaternary ammonium compound resistant staphylococci from the food industry. Int J Food Microbiol 48:211–219CrossRefPubMedGoogle Scholar
- 75.Heir E, Sundheim G, Holck AL (1999) The qacG gene on plasmid pST94 confers resistance to quaternary ammonium compounds in staphylococci isolated from the food industry. J Appl Microbiol 86:378–388CrossRefPubMedGoogle Scholar
- 76.Heir E, Sundheim G, Holck AL (1998) The Staphylococcus qacH gene product: a new member of the SMR family encoding multidrug resistance. FEMS Microbiol Lett 163:49–56CrossRefPubMedGoogle Scholar
- 77.Anthonisen I, Sunde M, Steinum TM, Sidhu MS, Sørum H (2002) Organization of the antiseptic resistance gene qacA and Tn 552 -related β -lactamase genes in multidrug-resistant Staphylococcus haemolyticus strains of animal and human origins. Antimicrob Agents Chemother 46:3606–3612CrossRefPubMedPubMedCentralGoogle Scholar
- 78.Langsrud S, Sundheim G, Borgmann-Strahsen R (2003) Intrinsic and acquired resistance to quaternary ammonium compounds in food-related Pseudomonas spp. J Appl Microbiol 95(4):874–82CrossRefPubMedGoogle Scholar
- 79.Alam MM, Ishino M, Kobayashi N (2003) Analysis of genomic diversity and evolution of the low-level antiseptic resistance gene smr in Staphylococcus aureus. Microb Drug Resist 9:S-1–S-7CrossRefGoogle Scholar
- 80.Littlejohn TG, DiBerardino D, Messerotti LJ, Spiers SJ, Skurray RA (1991) Structure and evolution of a family of genes encoding antiseptic and disinfectant resistance in Staphylococcus aureus. Gene 101:59–66CrossRefPubMedGoogle Scholar
- 81.Paulsen IT, Brown MH, Dunstan SJ, Skurray RA (1995) Molecular characterization of the Staphylococcal multidrug resistance export protein QacC. J Bacteriol 177:2827–2833CrossRefPubMedPubMedCentralGoogle Scholar
- 82.Gillings MR, Holley MP, Stokes HW (2009) Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms. FEMS Microbiol Lett 296:282–288CrossRefPubMedGoogle Scholar
- 83.Gillings MR, Xuejun D, Hardwick SA, Holley MP, Stokes HW (2009) Gene cassettes encoding resistance to quaternary ammonium compounds: a role in the origin of clinical class 1 integrons? Int Soc Microb Ecol J 3:209–215Google Scholar
- 84.Recchia GD, Hall RM (1995) Gene cassettes: a new class of mobile element. Microbiology 141:3015–3027CrossRefPubMedGoogle Scholar
- 85.Partridge SR, Recchia GD, Stokes HW, Hall M (2001) Family of Class 1 integrons related to In4 from Tn 1696. Society 45:3014–3020Google Scholar